Skip to main content
KN $38.51 +1.88%
KN logo

KN · Knowles Corp

Track KN — free
$38.51 +0.71 (+1.88%) At close · Aug 14
Market Cap
$3.23B
Shares
85.56M
All earnings calls

Earnings call · FY2026 Q1

Knowles Corp Q1 FY2026 Earnings Call

Knowles Corp Q1 FY2026 Earnings Call

Concluded Apr 23, 2026 Audio replay
Apr 23, 2026 32:00 33 turns
Period
FY2026 Q1
Runtime
32:00
Sources
4 artifacts

Executive readout · one minute

What matters this quarter

Knowles reported Q1 2026 revenue of $153 million, up 16% year over year and at the high end of guidance, with non-GAAP EPS of $0.27, up 50% year over year. Both segments grew double digits with significant gross margin expansion, and management raised expectations for full-year 2026 organic revenue growth to above the high end of the 4%–6% target.

Precision Devices segment growth 40 Energy order ramp 20 Long-term supply agreements in defense 17 Defense market demand 16 Capacity utilization and expansion 15 MedTech and Specialty Audio 12

Management tone

Confident

Net tone +82 · low hedging

Grounding quotes
  • “We had strong organic growth in the first quarter. We delivered revenue of $153 million, up 16% year over year, at the high end of our guided range. EPS of $0.27, up 50% year over year, exceeded the high end of our guided range”
  • “A robust pipeline of new design wins coupled with favorable secular trends gives me confidence in our ability to continue to grow revenue above the high end of the organic growth target of 6% to 8% for Precision Devices in 2026”
  • “I continue to be excited by the strength of our business and the momentum we exited the first quarter with. We are well positioned for continued strong organic revenue growth and margin expansion through 2026”
  • “we now expect our revenue growth in 2026 to be above the high end of our target organic revenue range of 4% to 6% that we provided at our Investor Day in May”

Forward guidance

1 guided metrics

Management's latest ranges and targets are included below.

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $153.10M +15.8% YoY
Diluted EPS $0.11
Gross margin 43.8% +3.5 pp YoY
Net income $9.70M

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • Q1 revenue of $153M up 16% YoY at the high end of guided range, and non-GAAP EPS of $0.27 up 50% YoY exceeding the high end of guidance.
  • Precision Devices revenue up 17% YoY to $85M with segment gross margin of 39.2%, up 350bps YoY, and book-to-bill of 1.19 (sixth consecutive quarter above 1).
  • MedTech and Specialty Audio revenue up 14% YoY to $68M with Q1 gross margin of 53.5%, up 480bps YoY on capacity utilization and favorable mix.
  • Expects 2026 organic revenue growth above the high end of the 4%–6% target set at the May 2025 Investor Day, citing momentum and healthy backlog.
  • Defense demand driven by OEM programs, share gains, sole-supplier positions, and expected stock replenishment tied to the Iran conflict supporting 2027 and beyond.
  • Energy order ramp in Precision Devices expected to drive ~200–250bps of PD segment margin expansion in the back half, with all required equipment already on site.

Risks & pressure points

  • Q1 cash utilized in operating activities was $1M (within guidance but still a use of cash).
  • Hearing health end market expected to revert to normal historical growth in 2026, so MedTech and Specialty Audio full-year growth guided back to 2%–4% despite a strong 14% Q1.
  • Energy order production ramp is currently a headwind weighing on Precision Devices segment margins.
  • Higher factory costs from ramping specialty film production capacity are partially offsetting Precision Devices margin gains.

Key moments

Jump directly to management's words in the synchronized transcript.

“I believe Knowles Corporation has entered a period of accelerated organic growth. With a very healthy backlog of existing orders, we now expect our revenue growth in 2026 to be above the high end of our target organic revenue range of 4% to 6% that we provided at our Investor Day in May.” Jeffrey Niew, CEO
“Our first quarter performance, combined with a robust backlog and increased order activity throughout the first four months of the year, give me confidence in our ability to deliver an increase in 2026 adjusted EBITDA above our cumulative annual growth target of 10% to 14%.” John Anderson, CFO

Guidance from the call

Stated verbally and extracted from the transcript.

Metric Guided
MSA gross margins
full year 2026
51%

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

Precision Devices$85.10M +17.4% YoY
MedTech Specialty Audio$68.00M +13.9% YoY

Capital returned

Buybacks
$7.50M
Full-screen source Call document